A first comparative study of purpurinimide-based fluorinated vs. Nonfluorinated photosensitizers for photodynamic therapy

Photochemistry and Photobiology

Volumn 76, Issue 5, 2002, Pages 555-559

  Gryshuk, Amy L ^a   Graham, Andrew ^a   Pandey, Suresh K ^a   Potter, William R ^a   Missert, Joseph R ^a   Oseroff, Allan ^a   Dougherty, Thomas J ^a   Pandey, Ravindra K ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 DEVINYL 3 O (1' BUTYLOXY)ETHYLPURPURIN 18 N [3,5 BIS(TRIFLUOROMETHYL)BENZYL]IMIDE; ANTINEOPLASTIC AGENT; PHOTOFRIN; PHOTOSENSITIZING AGENT; PURPURIN 18 N BUTYL 3 O [1' [3'',5'' BIS(TRIFLUOROMETHYL)BENZYLETHER]]IMIDE; PURPURIN DERIVATIVE; PURPURINIMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; DRUG SYNTHESIS; DRUG UPTAKE; FIBROSARCOMA; FLUORINATION; IN VITRO STUDY; IN VIVO STUDY; ISOMER; LIPOPHILICITY; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PHOTOTOXICITY;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG SCREENING ASSAYS, ANTITUMOR; FLUORINE; LIGHT; MICE; MICE, INBRED C3H; MOLECULAR STRUCTURE; NEOPLASM TRANSPLANTATION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; SARCOMA, EXPERIMENTAL; TIME FACTORS;

ANIMALIA;

EID: 0036877763     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/0031-8655(2002)076<0555:AFCSOP>2.0.CO;2     Document Type: Article

References (30)

1. Dougherty, T. J., C. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan and Q. Peng (1998) Photodynamic therapy. J. Natl. Cancer Inst. 90, 889-905.
2. Sharman, W. M., C. M. Allen and J. E. van Lier (1999) Basic principles and clinical applications. Curr. Trends Drug Discov. Today 4, 507-511.
3. Pandey, R. K. and G. Zheng (2000) The Porphyrin Handbook (Edited by K. M. Kadish, K. M. Smith and R. Guilard), Vol. 6, chapter 43, Academic Press, Boston.
4. Lobel, J., I. MacDonald, M. Ciesielski, T. J. Barone, W. R. Potter, J. Plooina, R. J. Plunkett, R. A. Fenstermaker and T. J. Dougherty (2001) 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: implications for photodynamic therapy. Lasers Surg. Med. 29, 397-405.
5. Pandey, R. K., A. B. Sumlin, W. R. Potter, D. A. Bellnier, B. W. Henderson, S. Constantine, M. Aoudia, M. A. J. Rodgers, K. M. Smith and T. J. Dougherty (1996) Synthesis, photophysical properties, and photodynamic efficacy of alkyl ether analogs of chlorophyll-a derivatives. Photochem. Photobiol. 52, 194-205.
6. Henderson, B. W., D. A. Bellinier, W. R. Graco, A. Sharma, R. K. Pandey, L. Vaughan, K. R. Weishaupt and T. J. Dougherty (1997) A quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy. Cancer Res. 57, 4000-4007.
7. Zheng, G., W. R. Potter, S. H. Camacho, J. R. Missert, G. Wang, D. A. Bellnier, B. W. Henderson, M. A. J. Rodgers, T. J. Dougherty and R. K. Pandey (2001) Synthesis, photophysical properties, tumor uptake, and preliminary in vivo photosensitizing efficacy of a homologous series of a 3-(1′alkyloxy)ethyl-3-devinylpurpurin-18-N-alkylimides with variable lipophilicity. J. Med. Chem. 44, 1540-1559.
8. Zheng, G., W. R. Potter, A. Sumlin, T. J. Dougherty and R. K. Pandey (2000) Photosensitizers related to purpurin-18-N-alkylimides: a comparative in vivo tumoricidal ability of ester versus amide functionalities. Bioorg. Med. Chem. Lett. 10, 123-127.
9. Allen, C. M., R. Langlois, W. M. Sharman, C. L. Madeleine and J. E. Van Lier (2002) Photodynamic properties of amphiphilic derivatives of aluminum tetrasulfophthalocyanine. Photochem. Photobiol. 76, 208-216. [See references therein]
10. Oleinick, N. L., A. R. Antunez, M. E. Clay, B. D. Rihter and M. E. Kenney (1993) New phthalocyanine photosensitizers for photodynamic therapy. Photochem. Photobiol. 57, 242-247.
11. Surya Prakash, G. K. and A. K. Yudin (1997) Chem. Rev. 97, 757.
12. Banks, R. E., B. E. Smart and J. C. Tatlow (1994) Organofluorine Chemistry - Principles and Commercial Applications. Plenum Press, New York.
13. Smith, K. M., D. A. Goff and D. J. Simpson (1985) Meso substitution of chlorophyll derivatives: direct route for transformation of bacteriopheophorbides d into bacteriopheo-pheorbides c. J. Am. Chem. Soc. 107, 4941-4954.
14. Smith, K. M. (1975) Porphyrins and Metalloporphyrins (Edited by K. M. Smith), Elesvier Sci. Pub., Amsterdam.
15. Tropper, F. D. F. O. Anderson, S. Brown and R. Roy (1992) Phase transfer catalysis as a general and stereo-selective entry into glycosyl azides from glycosyl halides. Synthesis, 618-620.
16. Pandey, R. K., W. R. Potter, I. Meunier, A. B. Sumlin and K. M. Smith (1995) Evaluation of new benzoporphyrin derivatives with enhanced PDT efficacy. Photochem. Photobiol. 62, 764-768.
17. Wilson, B. C., T. J. Farrell and M. S. Patterson (1990) An optical fiber-based diffuse reflectance spectrometer for non-invasive investigations of photodynamic sensitizers in vivo. In Future Directions and Applications in Photodynamic Therapy, Vol. IS6 (Edited by C. J. Gomer), pp. 219-232, Proceedings SPIE, Bellingham, Washington DC.
18. Patterson, M. S., E. Schwartz and B. C. Wilson (1989) Quantitative reflectance spectroscopy for the noninvasive measurement of photosensitizer concentration in tissue during photodynamic therapy. Proc. SPIE 1065, 114-122.
19. Morgan, J., W. R. Potter and A. Oseroff (2000) Comparison of photodynamic targets in a carcinoma cell line and its mitochondrial DNA-deficient derivative. Photochem. Photobiol. 70, 747-757.
20. Sitnik, T. M., J. A. Hampton and B. W. Henderson (1998) Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. Br. J. Cancer 77, 1386-1394.
21. Ferrario, A., K. Von Tiehl, S. Wong, M. Luna M, C. J. (2002) Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response. Cancer Res. 62, 3956-3961.
22. Hanlon, J. G., K. Adams, A. J. Rainbow, R. S. Gupta and C. J. Singh (2001) Induction of Hsp60 by Photofrin-mediated photodynamic therapy. J. Photochem. Photobiol. B: Biol. 64, 55-61.
23. Kessel, D. and Y. Luo (1999) Photodynamic therapy: a mitochondrial inducer of apoptosis. Cell Death Differ. 6, 28-35.
24. Pandey, R. K., D. A. Bellnier, K. M. Smith and T. J. Dougherty (1991) Chlorin and porphyrin derivatives as potential photosensitizers in photodynamic therapy. Photochem. Photobiol. 53, 65-72.
25. Dougherty, T. J., A. B. Sumlin, W. R. Graco, K. R. Weishaupt, L. A. Vaughan and R. K. Pandey (2002) The role of the peripheral benzodiazepine receptor in photodynamic activity of certain pyropheophorbide ether photosensitizers: albumin site II as a surrogate marker for activity. Photochem. Photobiol. 76, 91-97.
26. Bellnier, D. A., B. W. Henderson, R. K. Pandey, W. R. Potter and T. J. Dougherty (1993) Murine pharmacokinetics and antitumor efficacy of the photodynamic photosensitizer 2-[1-hexyloxyethyl]-2-devinylpyropheophorbide-a. Photochem. Photobiol. 20, 55-61.
27. Kessel, D., Y. Luo, P. Mathieu and J. Reiners Jr. (2000) Determinants of the apoptotic response to lysosomal photodamage. Photochem. Photobiol. 71, 196-200.
28. Olenick, N. L., R. L. Morris and I. Belichenko (2001) The role of apoptosis in response to photodynamic therapy: what, where, why and how. Photochem. Photobiol. Sci. 1, 1-21.
29. Usuda, J., S. M. Chiu, K. Azizuddin, L. Y. Xue, M. Lam, A. L. Nieminen and N. L. Oleinick (2002) Promotion of photodynamic therapy-induced apoptosis by the mitochondrial protein Smac/DIABLO: dependence on Bax. Photochem. Photobiol. 76, 217-223.
30. Chen, Y., A. Graham, W. Potter, J. Morgan, L. Vaughan, D. A. Bellnier, B. W. Henderson, A. Oseroff, T. J. Dougherty and R. K. Pandey (2002) Bacteriopurpurinimides: highly stable and potent photosensitizers for photodynamic therapy. J. Med. Chem. 2, 255-258.